Dmitry S. Khan

Dmitry S. Khan

Auto-generated profile, based on publicly available information

Dmitry S. Khan

Primorsky Regional Clinical Hospital No. 1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
NSN.A. Shamalov
N.A. Shamalov
DKD.R. Khasanova
D.R. Khasanova
I(Igor Voznyuk (Voznjouk)
Igor Voznyuk (Voznjouk)
AAA.M. Alasheev
A.M. Alasheev
DKD.S. Khan
D.S. Khan
EGE.I. Gusev
E.I. Gusev
Introduction. Ischemic stroke (IS) remains a serious medical and social issue due to its high prevalence, mortality, and resulting disability. Reperfusion therapy is an effective method of treating patients with IS. Objective. The aim of this study was to examine the results of implementation of reperfusion technologies for the treatment of IS in the Russian Federation. Material and methods. The analysis was based on nationwide data collected from 2015 through the first quarter of 2025. The following indicators were assessed: the proportion of IS patients admitted to stroke units within the first 4.5 hours after symptom onset; the frequency of intravenous thrombolytic therapy (IVT), including the use of telemedicine technologies for IVT administration; the rate of thrombectomy; and the hospital mortality rate from IS. The implementation of telemedicine technologies was evaluated based on the presence of teleconsulted primary stroke units (tele-PSUs) in each region and the proportion of IS patients who received IVT in tele-PSUs. Results. Over the study period, an increase was observed in the proportion of IS patients admitted within 4.5 hours of symptom onset — from 23% in 2015 to 31% in 2024. The frequency of IVT and thrombectomy procedures increased from 2% and 0.1% in 2015 to 10.2% and 2.8% in the first quarter of 2025, respectively. The rate of IVT performed in tele-PSUs in 2024 was 13.6% of IS patients admitted to tele-PSUs. The ischemic stroke mortality rate decreased from 16.8% in 2015 to 12.6% in the first quarter of 2025. Conclusions. Reperfusion therapy technologies for IS are being actively implemented across the country, significantly improving clinical approaches to stroke management. Increasing the number of reperfusion procedures will contribute to improved patient outcomes, reduced mortality, and increase the number of individuals achieving favorable recovery of neurological functions.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
MSM.A. Soldatov
M.A. Soldatov
LKL.V. Klimov
L.V. Klimov
ATA.P. Tolmachev
A.P. Tolmachev
TKT.V. Kiseleva
T.V. Kiseleva
OAO.V. Androfagina
O.V. Androfagina
NSN.A. Shamalov
N.A. Shamalov
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка безопасности и эффективности тромболитической терапии (ТЛТ) препаратом Ревелиза (алтеплаза) у пациентов с ишемическим инсультом (ИИ) в реальной клинической практике. МАТЕРИАЛ И МЕТОДЫ Проведено открытое проспективное многоцентровое неинтервенционное регистровое исследование, в которое были включены 550 пациентов с ИИ — 259 (47,1%) женщин и 291 (52,9%) мужчина; средний возраст 67,7±12,6 года. Всем пациентам в течение 4,5 ч от начала развития заболевания была проведена ТЛТ препаратом Ревелиза и согласно протоколу реперфузионной терапии ИИ выполнялось клиническое, инструментальное и лабораторное обследование. Симптомную геморрагическую трансформацию (ГТ) определяли в соответствии с критериями исследования ECASS 3. РЕЗУЛЬТАТЫ Большинство (95,8%) пациентов страдали гипертонической болезнью, у 69,6% — была выявлена хроническая сердечная недостаточность, у 53,8% — ишемическая болезнь сердца, у 38,7% — отмечались различные нарушения сердечного ритма, 20,7% — страдали сахарным диабетом 2-го типа. Через 1 сут после ТЛТ улучшение на 4 балла и более по шкале NIHSS было отмечено у 45% пациентов. Средний показатель динамики по шкале инсульта NIHSS через 1 сут составил –3,2±4,7, на 7-е сутки — –4,4±6,1 (p<0,0001). ГТ очага поражения головного мозга развилась в 10,9% случаев, симптомная ГТ была диагностирована у 12 (2,3%) больных. Показатель больничной летальности составил 12,7%. Доля пациентов с хорошим функциональным восстановлением (0—2 балла по модифицированной шкале Рэнкина) при выписке, на 30 и 90-й дни составила 44,7, 59,2 и 68,5% соответственно. ЗАКЛЮЧЕНИЕ Проведение ТЛТ препаратом Ревелиза у пациентов с ИИ приводит к статистически значимому регрессу неврологических симптомов. Значительная доля пациентов достигает благоприятного клинического исхода при выписке из стационара и в отдаленном периоде. Полученные данные по эффективности и профилю безопасности соотносятся с ранее опубликованными регистровыми исследованиями алтеплазы при ИИ.

3 September 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
AAA.M. Alasheev
A.M. Alasheev
EPE.V. Prazdnichkova
E.V. Prazdnichkova
ABA.A. Belkin
A.A. Belkin
TKT.V. Kiseleva
T.V. Kiseleva
DKD.S. Khan
D.S. Khan
NSN.A. Shamalov
N.A. Shamalov
Objective. To analyze the impact of primary vascular units using teleconsulting (tele-PVU) on the accessibility and quality of specialized medical care for patients with cerebrovascular accidents (CVAs). Material and methods. The study is based on data from a survey of the chief neurology consultants of 85 constituent entities of the Russian Federation and anonymized information about patients treated in tele-PVUs in 2023. The analysis included accessibility to care, the percentage of patients receiving thrombolytic therapy (TLT), and mortality. Statistical analysis was carried out using IBM SPSS Statistics v.25.0 and Microsoft Excel 2016. Results. Establishing tele-PVUs has increased the accessibility of TLT in regions with a low population density. The frequency of TLT among patients with ischemic stroke in tele-PVUs was 9.8%, exceeding the average for the Russian Federation. Tele-PVUs also contributed to a reduction in the time from the onset of stroke symptoms to the start of treatment. In several regions, there has been a significant increase in the percentage of patients receiving reperfusion therapy. However, limitations were identified regarding the lack of qualified specialists and technical conditions for telemedicine consultations. Conclusion. The establishment of new units has increased the accessibility of medical care, including reperfusion therapy for stroke patients in regions with a low population density and/or prolonged medical evacuation to the nearest specialized unit. However, for further implementation of this system, it is necessary to continue work on solving technical and organizational issues and ensure the integration of telemedicine into the existing medical system.

29 June 2026 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
NGNikita I. Grachev
Nikita I. Grachev
YKYevgeny I. Kretov
Yevgeny I. Kretov
MLMark A/ Loskutnikov
Mark A/ Loskutnikov
ALAndrei L. Lukyanov
Andrei L. Lukyanov
DSDmitry Yu. Saiko
Dmitry Yu. Saiko
APAndrey V. Popov
Andrey V. Popov
Highlights For the first time in real-world clinical practice across several Russian regions, the high reproducibility and efficacy of the domestic Grasper stent-retriever for mechanical thrombectomy in stroke patients have been demonstrated. An unique routing ecosystem “UDAR” was developed, integrating the pre-hospital stage, “Tele-PVU” telemedicine support, and automated 5–7-minute express CT scan evaluation driven by artificial intelligence. The synergy of digital control and domestic medical devices enabled a 2.5-fold increase in mechanical thrombectomy volumes and reduced hospital mortality from ischemic stroke by 8.1%.   Aim . Analyze the results of the pilot project “UDAR” (Smile, Movement, Articulation, Solution) on reorganizing the routing of patients with acute cerebral blood circulation disorders (AHC) when using telemedicine in the territory of Primordia, to assess the effectiveness of modern methods of reperfusion using domestic stencil-reducers. Methods . The total number of patients suspected stroke included in the study was 18500. All patients at the pre-hospital stage were examined by a paramedic/ doctor of the emergency medical team, who entered on the tablet into the program “UDAR” patient data, then information was sent to the questionnaire of the program “UDAR” with automatic notification of the control center on the basis of a regional vascular center (RVC). The on-duty neurologist of the RVC then analyzed the data and gave recommendations for further routing to the primary vascular unit (PVU) or RVC (with LAMS > 3 points). If necessary, the neurologist of the RVC could conduct a telemedicine consultation with the medical doctor of the emergency medical team by video call to clarify the neurological status of the patient. Upon arrival of the patient in the PVU and CT-study of the brain, data was loaded into “UDAR” program. Control center radiologist had access to the patient’s CT scans. The first series of images was processed by artificial intelligence (AI) with identification of areas of detected pathologies, determination of the extent of lesions, scoring according to the ASPECTS scale prepared by an X-ray report. The second series was a native CT image. Based on the results of the examinations, the neurologist decided to leave the patient in the PVU or transfer to the RVC for mechanical thrombosis extraction. Results . During the lifetime of the project, there was an increase in the frequency of thrombolytic therapy (TLT) from 3.9% to 8.6% (by 4.6%), the number of mechanical thrombosis extractions increased by 1.5 times in 2022 compared to 2021 and 2.5 times in 2023 compared to 2021. Hospital mortality rates from ischaemic stroke in the Primorsky PVU have decreased from 21.7% in 2021 to 14.9% in 2022 and 13.6% in 2023. Conclusion . According to the data obtained from the pilot project, it was found that it is advisable to scale its results to other regions of the country.